PolyTherics is a pioneering biomedical polymer company that focuses on developing innovative therapeutic solutions. Their flagship technology, TheraPEG, leverages site-specific PEGylation methods to enhance the efficacy of biopharmaceuticals. The company collaborates with industry leaders in biopharmaceuticals to integrate their technology into advanced treatments. Established in 2001, PolyTherics operates in the Biotechnology, Health and Wellness, and Medical Devices sectors. Their recent milestone includes a £13.50M Venture Round investment on 26 July 2013, with Invesco, Mercia Fund Managers, and Imperial Innovations contributing as investors. Additionally, the company is actively building a portfolio of optimized clinical candidates to further their impact on therapeutic innovation in the industry.
PolyTherics
Pioneering biomedical polymer technologies for therapeutic innovation and partnering with biopharmaceutical leaders to enhance advanced treatments
General Information
BounceWatch is an independent company data service, not affiliated with PolyTherics. To contact PolyTherics, visit polytherics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does PolyTherics compare?
A PDF of PolyTherics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting PolyTherics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About PolyTherics
Business keywords: biomedical polymers, therapeutic innovation, biopharmaceutical, TheraPEG, technology development, clinical candidates
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | £13.50M | 3 |
|
26 Jul 2013 |
| Venture Round | £2.15M | 4 |
-logo.jpg){kind=logo}
|
07 Sep 2011 |
| Series C | $4.00M | 3 |
|
15 Apr 2010 |
| Venture Round | $350.00K | - |
|
30 Nov 2007 |
| Venture Round | £2.30M | - |
|
20 Jun 2007 |
PolyTherics Alternatives & Competitors
Perseus Proteomics discovers therapeutic antibodies and runs clinical programs on the drugs.
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developin...
Developing novel serpin-based therapies
FAQ About PolyTherics
Source: BounceWatch company record for PolyTherics, https://bouncewatch.com/company/polytherics, updated 27 December 2024. When citing, please name BounceWatch and link this page.
